2 research outputs found

    Prevalence of epilepsy in a case series of multiple sclerosis patients PrevalĂȘncia de epilepsia numa coorte de pacientes com esclerose mĂșltipla

    No full text
    OBJECTIVE: The prevalence of epilepsy in multiple sclerosis (MS) patients has been a subject of interest for some years. The objectives of this study were to describe the clinical, radiological and electroencephalographic characteristics of epileptic seizures and to calculate the prevalence of epilepsy in a case series of MS patients. METHOD: Medical charts of MS patients were reviewed and patients who had suffered epileptic seizures were identified. RESULTS: Of 160 cases analyzed, 5 had suffered epileptic seizures and one had comorbid mesial hippocampal sclerosis, confirmed by magnetic resonance imaging in a patient with complex partial seizures that began fifteen years prior to her diagnosis of MS. In the other four patients, seizures occurred both during the acute phase of the disease and in the chronic phase. CONCLUSION: The prevalence of epileptic seizures in MS patients in this study was 2.5%, similar to that found in other studies.OBJETIVO: A prevalĂȘncia da epilepsia em pacientes com esclerose mĂșltipla (EM) tem sido objeto de interesse hĂĄ vĂĄrios anos. Os objetivos deste estudo foram descrever as caracterĂ­sticas clĂ­nicas, radiolĂłgicas e eletroencefalogrĂĄficas das crises epilĂ©pticas e estimar a prevalĂȘncia de epilepsia na EM numa sĂ©rie de casos. MÉTODO: Foram revisados prontuĂĄrios de pacientes com EM e identificados os casos que apresentaram crise epilĂ©ptica. RESULTADOS: Dos 160 casos analisados, cinco apresentaram crise epilĂ©ptica, sendo que, um caso, houve a presença de comorbidade com esclerose mesial do hipocampo, comprovada atravĂ©s de ressonĂąncia magnĂ©tica numa paciente com crises parciais complexas iniciadas quinze anos antes do diagnĂłstico de EM. Nos outros quatro pacientes, as crises ocorreram tanto na fase aguda da doença, como na fase crĂŽnica. CONCLUSÃO: A prevalĂȘncia de crises epilĂ©ticas nos pacientes com EM neste estudo foi de 2,5%, semelhante Ă  encontrada em outros estudos
    corecore